Symptomatic carotid artery stenosis: what is the preferred treatment?
Daniel S Menees1, Eric R Bates
1Division of Cardiovascular Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Insights
Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are effective treatments for carotid artery stenosis, a common cause of stroke. Both procedures offer benefits, with the choice depending on individual patient factors and surgical risk.
Area of Science:
- Neurology
- Vascular Surgery
- Cardiology
Background:
- Stroke is a leading cause of death and disability, with carotid artery disease accounting for 15-20% of cases.
- Carotid endarterectomy (CEA) is a proven treatment for symptomatic carotid stenosis, reducing stroke risk in select patients.
- Carotid artery stenting (CAS) has emerged as an alternative, particularly for high-risk surgical candidates.
Purpose of the Study:
- To compare the efficacy and safety of CEA and CAS for treating carotid artery stenosis.
- To identify patient characteristics that may favor one procedure over the other.
- To review the current evidence on revascularization strategies for carotid artery disease.
Main Methods:
- Systematic review and meta-analysis of existing studies comparing CEA and CAS.
- Analysis of patient outcomes including stroke, death, and myocardial infarction.
- Evaluation of factors influencing treatment choice, such as patient age, stenosis severity, and anatomy.
Main Results:
- Both CEA and CAS reduce the risk of stroke and death in symptomatic patients with significant carotid stenosis.
- CAS may have a higher risk of nondisabling stroke, but this is mitigated by embolic protection devices.
- CAS is associated with a lower risk of myocardial infarction compared to CEA, with no difference in disabling stroke or death.
- Operator experience and patient-specific factors influence outcomes, with CEA potentially favored in older patients with complex anatomy and CAS in younger patients or those with restenosis.
Conclusions:
- CEA and CAS are complementary revascularization strategies for carotid artery stenosis.
- The optimal treatment choice depends on a comprehensive assessment of individual patient risk factors, anatomy, and procedural considerations.
- Optimal medical therapy remains crucial for all patients to manage secondary risk factors and prevent future cardiovascular events.
Abstract:
Stroke is a major cause of mortality, morbidity, and disability. Carotid artery disease is the etiology for 15% to 20% of stroke. Carotid endarterectomy (CEA) reduces the risk of ipsilateral stroke and death in symptomatic patients with 50% to 99% carotid artery stenosis when the operative risk of stroke or death is less than 6%. Treatment benefit is greater with earlier surgery, more severe stenoses, and older age. Recently, carotid artery stenting (CAS) has emerged as a treatment option, especially in patients with high surgical risk due to anatomic or clinical variables. Nondisabling stroke risk may be higher with CAS than CEA, but the difference is narrowed with the use of embolic protection devices. The risk for myocardial infarction is lower with CAS than CEA. There is no difference in risk for disabling stroke or death. Worse results with new or low-volume CAS operators is a concern. CEA and CAS are complementary revascularization strategies. CEA may be preferred in older patients with complex anatomy or bulky plaques. CAS may be preferred in younger patients and those with restenosis, history of neck radiation, surgical contraindications, or surgically inaccessible lesions. The role for optimal medical therapy as an alternative treatment strategy remains to be defined. Nevertheless, all patients should be treated with lifestyle interventions and secondary risk factor control to target levels to reduce the risk of subsequent atherosclerotic events.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Aneurysm III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Mitral Stenosis III: Medical Management
